These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 5592607)

  • 21. [Present status and therapeutic prospectives on allergic rhinitis].
    Cipolla C; D'Antuono G; Giannini A; Golfera A
    G Clin Med; 1983 Dec; 64(12):571-8. PubMed ID: 6423435
    [No Abstract]   [Full Text] [Related]  

  • 22. Safety and efficacy of allergen immunotherapy in the treatment of allergic rhinitis and asthma in real life.
    Zeldin Y; Weiler Z; Magen E; Tiosano L; Kidon MI
    Isr Med Assoc J; 2008 Dec; 10(12):869-72. PubMed ID: 19160945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Preventive immunotherapy].
    Boquete M; Carballada F; Expósito F; González A
    Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis.
    Casale TB; Busse WW; Kline JN; Ballas ZK; Moss MH; Townley RG; Mokhtarani M; Seyfert-Margolis V; Asare A; Bateman K; Deniz Y;
    J Allergy Clin Immunol; 2006 Jan; 117(1):134-40. PubMed ID: 16387596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The significance of infection for the allergic disorders of the respiratory tract. IV. The results of immunotherapy in patients with bronchial asthma and vasomotor rhinitis].
    Zavázal V
    Allerg Asthma (Leipz); 1965; 11(6):278-85. PubMed ID: 5887935
    [No Abstract]   [Full Text] [Related]  

  • 26. Allergic rhinitis.
    Kemp AS
    Paediatr Respir Rev; 2009 Jun; 10(2):63-8. PubMed ID: 19410204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific local immunotherapy in young allergic subjects.
    Passàli D; De Seta E; Masieri S; Bellussi L
    Acta Otorhinolaryngol Ital; 1983; 3(4):403-8. PubMed ID: 6659927
    [No Abstract]   [Full Text] [Related]  

  • 28. Study on changes in the level of serum IL-4 and soluble CD 23(s-CD23) with immunotherapy in nasal allergy patients.
    Ito H; Suzuki M; Mamiya S; Takagi I; Baba S
    Acta Otolaryngol Suppl; 1996; 525():98-104. PubMed ID: 8908280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiallergen immunotherapy for allergic rhinitis and asthma.
    Nelson HS
    J Allergy Clin Immunol; 2009 Apr; 123(4):763-9. PubMed ID: 19217653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-IgE therapy combined with specific immunotherapy: pro.
    Wahn U; Hamelmann E
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2003; (94):269-71. PubMed ID: 15119047
    [No Abstract]   [Full Text] [Related]  

  • 31. Serum vascular endothelial growth factor and sublingual immunotherapy.
    Ciprandi G; Colombo BM; Murdaca G; De Amici M
    Allergy; 2008 Jul; 63(7):945-6. PubMed ID: 18588566
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical efficacy of grass-pollen immunotherapy.
    Longo G; Barbi E
    N Engl J Med; 2000 Jan; 342(1):58-9. PubMed ID: 10627214
    [No Abstract]   [Full Text] [Related]  

  • 33. [Contribution of allergen immunotherapy using Phostal in the treatment of seasonal allergic rhinitis (two years of use)].
    Bartosíková L; Necas J; Bartosík T; Pavlík M; Fránová J
    Ceska Slov Farm; 2008 Apr; 57(2):99-102. PubMed ID: 18578420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RAST-based immunotherapy.
    Nalebuff DJ; Fadal RG
    Rhinology; 1984 Mar; 22(1):11-9. PubMed ID: 6729355
    [No Abstract]   [Full Text] [Related]  

  • 35. Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial.
    Walker SM; Pajno GB; Lima MT; Wilson DR; Durham SR
    J Allergy Clin Immunol; 2001 Jan; 107(1):87-93. PubMed ID: 11149996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sublingual immunotherapy: where do we stand? Present and future.
    Passalacqua G; Pawankar R; Baena-Cagnani CE; Canonica GW
    Curr Opin Allergy Clin Immunol; 2009 Feb; 9(1):1-3. PubMed ID: 19106697
    [No Abstract]   [Full Text] [Related]  

  • 37. [The value and possibilities of immunotherapy in the treatment of allergic rhinitis].
    Pfaar O; Hörmann K; Klimek L
    MMW Fortschr Med; 2006 Feb; 148(5):28-32. PubMed ID: 16518935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allergen immunotherapy in intermittent allergic rhinitis reduces the intracellular expression of IL-4 by CD8+ T cells.
    Glück J; Rogala B; Rogala E; Oleś E
    Vaccine; 2007 Dec; 26(1):77-81. PubMed ID: 18054415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunotherapy, can we improve it?
    Waldbott GL
    Ann Allergy; 1980 Jul; 45(1):56-8. PubMed ID: 7406243
    [No Abstract]   [Full Text] [Related]  

  • 40. Recent trends in the diagnosis and management of allergic rhinitis.
    Elango S
    Med J Malaysia; 2005 Dec; 60(5):672-6; quiz 677. PubMed ID: 16515128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.